Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Niloufar Keyhanmehr, Hossein Motedayyen & Nahid Eskandari. (2019) The Effects of Silymarin and Cyclosporine A on the Proliferation and Cytokine Production of Regulatory T Cells. Immunological Investigations 48:5, pages 533-548.
Read now
Read now
Guan-hai Dai, Chen-jie Fan, Ze-ming Ren, Xuan Chen, Ye-ling Tong, Zhen-hua Li, Xiao-jing Nie & Ke-qun Chai. (2017) The Mechanistic Antitumor Study of Myricanol 5-Fluorobenzyloxy Ether in Human Leukemic Cell Hl-60. Future Medicinal Chemistry 9:18, pages 2117-2127.
Read now
Read now
Yijing Li, Jingyi Hong, Haowen Li, Xiaoyu Qi, Yifei Guo, Meihua Han & Xiangtao Wang. (2017) Genkwanin nanosuspensions: a novel and potential antitumor drug in breast carcinoma therapy. Drug Delivery 24:1, pages 1491-1500.
Read now
Read now
Canhua Jiang, Shufang Jin, Zhisheng Jiang & Jie Wang. (2016) Inhibitory effects of silibinin on proliferation and lung metastasis of human high metastasis cell line of salivary gland adenoid cystic carcinoma via autophagy induction. OncoTargets and Therapy 9, pages 6609-6618.
Read now
Read now
Xing-Xing Zhu, Ya-Hui Ding, Yi Wu, Lin-Yan Qian, Hai Zou & Qiang He. (2016) Silibinin: a potential old drug for cancer therapy. Expert Review of Clinical Pharmacology 9:10, pages 1323-1330.
Read now
Read now
BRUNA COROMINAS-FAJA, Cristina Oliveras-Ferraros, ELISABET CUYÀS, Antonio Segura-Carretero, Jorge Joven, Begoña Martin-Castillo, ENRIQUE BARRAJÓN-CATALÁN, Vicente Micol, Joaquim Bosch-Barrera & JAVIERABEL MENENDEZ MENENDEZ. (2013) Stem cell-like ALDHbright cellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin. Cell Cycle 12:21, pages 3390-3404.
Read now
Read now
Articles from other publishers (50)
Sara Verdura, José Antonio Encinar, Alexei Gratchev, Àngela Llop-Hernández, Júlia López, Eila Serrano-Hervás, Eduard Teixidor, Eugeni López-Bonet, Begoña Martin-Castillo, Vicente Micol, Joaquim Bosch-Barrera, Elisabet Cuyàs & Javier A. Menendez. (2024) Silibinin is a suppressor of the metastasis-promoting transcription factor ID3. Phytomedicine 128, pages 155493.
Crossref
Crossref
Yibin Zhou, Fenglan Wang, Guangda Li, Jing Xu, Jingjing Zhang, Elizabeth Gullen, Jie Yang & Jing Wang. (2024) From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer. Frontiers in Immunology 15.
Crossref
Crossref
Abhishek Wahi, Priti Jain, Apurba Sinhari & Hemant R. Jadhav. (2023) Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents. Naunyn-Schmiedeberg's Archives of Pharmacology 397:2, pages 675-702.
Crossref
Crossref
Elif Ayazoglu Demir, Ahmet Mentese, Hatice Kucuk, Nihal Turkmen Alemdar & Selim Demir. (2023) The therapeutic effect of silibinin against 5‐fluorouracil‐induced ovarian toxicity in rats. Journal of Biochemical and Molecular Toxicology 37:9.
Crossref
Crossref
Hemlata Bhardwaj, Neeru Vasudeva & Sunil Sharma. (2023) Possible Mechanism and Pharmacological Activities of a Flavolignan
Silibinin. Current Bioactive Compounds 19:7.
Crossref
Crossref
Marta Gómez de Cedrón, Rocío Moreno Palomares & Ana Ramírez de Molina. (2023) Metabolo-epigenetic interplay provides targeted nutritional interventions in chronic diseases and ageing. Frontiers in Oncology 13.
Crossref
Crossref
Chetna Gupta, Aadya Jaipuria & Nikesh Gupta. (2022) Inhalable Formulations to Treat Non-Small Cell Lung Cancer (NSCLC): Recent Therapies and Developments. Pharmaceutics 15:1, pages 139.
Crossref
Crossref
Sally Abou Taleb, Yassmin Moatasim, Mohamed GabAllah & Marwa Hasanein Asfour. (2022) Quercitrin loaded cyclodextrin based nanosponge as a promising approach for management of lung cancer and COVID-19. Journal of Drug Delivery Science and Technology 77, pages 103921.
Crossref
Crossref
Rangnath Ravi, Md. Zeyaullah, Shubhrima Ghosh, Mohiuddin Khan Warsi, Renu Baweja, Abdullah M. AlShahrani, Abhijeet Mishra & Razi Ahmad. (2022) Use of gold nanoparticle-silibinin conjugates: A novel approach against lung cancer cells. Frontiers in Chemistry 10.
Crossref
Crossref
Sedat KAÇAR & Nuriye Ezgi BEKTUR AYKANAT. (2021) Silimarin SLIT2 Proteinini Aktive Ederek ve CXCR4 Ekspresyonunu Baskılayarak A549 Hücrelerini İnhibe EttiSilymarin Inhibited A549 Cells by Activating SLIT2 Protein and Suppressing Expression of CXCR4. Uludağ Üniversitesi Tıp Fakültesi Dergisi 47:3, pages 327-334.
Crossref
Crossref
Aviram Trachtenberg, Katarzyna Sidoryk, Somaya Alreate, Suchismita Muduli, Andrzej Leś, Marcin Cybulski & Michael Danilenko. (2021) Structure-Activity Relationship of Hydroxycinnamic Acid Derivatives for Cooperating with Carnosic Acid and Calcitriol in Acute Myeloid Leukemia Cells. Biomedicines 9:11, pages 1517.
Crossref
Crossref
Hardeep Singh Tuli, Sonam Mittal, Diwakar Aggarwal, Gaurav Parashar, Nidarshana Chaturvedi Parashar, Sushil Kumar Upadhyay, Tushar Singh Barwal, Aklank Jain, Ginpreet Kaur, Raj Savla, Katrin Sak, Manoj Kumar, Mehmet Varol, Ashif Iqubal & Anil Kumar Sharma. (2021) Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Seminars in Cancer Biology 73, pages 196-218.
Crossref
Crossref
Alexis Rugamba, Dong Young Kang, Nipin Sp, Eun Seong Jo, Jin-Moo Lee, Se Won Bae & Kyoung-Jin Jang. (2021) Silibinin Regulates Tumor Progression and Tumorsphere Formation by Suppressing PD-L1 Expression in Non-Small Cell Lung Cancer (NSCLC) Cells. Cells 10:7, pages 1632.
Crossref
Crossref
Sara Verdura, Elisabet Cuyàs, Verónica Ruiz-Torres, Vicente Micol, Jorge Joven, Joaquim Bosch-Barrera & Javier A. Menendez. (2021) Lung Cancer Management with Silibinin: A Historical and Translational Perspective. Pharmaceuticals 14:6, pages 559.
Crossref
Crossref
Tingting Wen, Lei Song & Shucheng Hua. (2021) Perspectives and controversies regarding the use of natural products for the treatment of lung cancer. Cancer Medicine 10:7, pages 2396-2422.
Crossref
Crossref
Rabia Akram, Haseeb Anwar, Azhar Rasul, Shoaib Ahmad Malik, Javeria Maqbool, Faiqa Sajid & Ghulam Hussain. 2021. Medicinal Plants for Lung Diseases. Medicinal Plants for Lung Diseases
229
256
.
Nahida Siddiqui, Lubna Abidin, Nazima Nisar, Irfan Ahmad & Ali Nasir Siddiqui. 2021. Polyphenols-based Nanotherapeutics for Cancer Management. Polyphenols-based Nanotherapeutics for Cancer Management
239
287
.
Suyan Xu, Hongyan Zhang, Aifeng Wang, Yongcheng Ma, Yuan Gan & Guofeng Li. (2020) Silibinin suppresses epithelial–mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1. Cellular & Molecular Biology Letters 25:1.
Crossref
Crossref
Meirong Huo, Honglan Wang, Ying Zhang, Han Cai, Pan Zhang, Lingchao Li, Jianping Zhou & Tingjie Yin. (2020) Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation. Journal of Controlled Release 321, pages 198-210.
Crossref
Crossref
Ramesh K. Bonta. (2020) Dietary Phenolic Acids and Flavonoids as Potential Anti-Cancer Agents: Current State of the Art and Future Perspectives. Anti-Cancer Agents in Medicinal Chemistry 20:1, pages 29-48.
Crossref
Crossref
Milad Ashrafizadeh, Zahra Ahmadi, Reza Mohammadinejad, Tahereh Farkhondeh & Saeed Samarghandian. (2020) Nano-soldiers Ameliorate Silibinin Delivery: A Review Study. Current Drug Delivery 17:1, pages 15-22.
Crossref
Crossref
Dominique Reed, Komal Raina & Rajesh Agarwal. 2020. Natural Products for Cancer Chemoprevention. Natural Products for Cancer Chemoprevention
161
208
.
Liyue Qin, Ziyu Chen, Liu Yang, Hailian Shi, Hui Wu, Beibei Zhang, Weiqi Zhang, Qi Xu, Fei Huang & Xiaojun Wu. (2019) Luteolin-7-O-glucoside protects dopaminergic neurons by activating estrogen-receptor-mediated signaling pathway in MPTP-induced mice. Toxicology 426, pages 152256.
Crossref
Crossref
Elisabet Cuyàs, Sara Verdura, Vicente Micol, Jorge Joven, Joaquim Bosch-Barrera, José Antonio Encinar & Javier A. Menendez. (2019) Revisiting silibinin as a novobiocin-like Hsp90 C-terminal inhibitor: Computational modeling and experimental validation. Food and Chemical Toxicology 132, pages 110645.
Crossref
Crossref
Altaf Mohammed, Jennifer T Fox & Mark Steven Miller. (2019) Cancer Chemoprevention: Preclinical In Vivo Alternate Dosing Strategies to Reduce Drug Toxicities. Toxicological Sciences 170:2, pages 251-259.
Crossref
Crossref
Nataliya B. Feldman, Tatiana I. Gromovykh, Natalia E. Sedyakina, Ivan I. KrasnyukJrJr & Sergey V. Lutsenko. (2018) Cytotoxic and Antitumor Activity of Liposomal Silibinin. BioNanoScience 8:4, pages 971-976.
Crossref
Crossref
Zohreh Jahanafrooz, Nasrin Motamed, Beate Rinner, Ahad Mokhtarzadeh & Behzad Baradaran. (2018) Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator. Life Sciences 213, pages 236-247.
Crossref
Crossref
Hong-rui Zhang. (2018) Artesunate Improves Drug Resistance of Lung Carcinomas Via Regulation of MiR-493-5p. Clinical surgery research communications 2:2.
Crossref
Crossref
Wen-qing Ge. (2018) MiR-539 Inhibits Inflammation in Renal Transplant Iscemia-Reperfusion Injury Via Blocking the MyD88/NF-κB Pathway. Clinical surgery research communications 2:2.
Crossref
Crossref
Dongjie Ma, Shanqing Li, Yushang Cui, Li Li, Hongsheng Liu, Yeye Chen & Xiaoyun Zhou. (2018) Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway. Oncology Letters.
Crossref
Crossref
Zhong-Wen Yuan, Ya-Zhuo Li, Zhong-Qiu Liu, Sen-ling Feng, Hua Zhou, Chang-Xiao Liu, Liang Liu & Ying Xie. (2018) Role of tangeretin as a potential bioavailability enhancer for silybin: Pharmacokinetic and pharmacological studies. Pharmacological Research 128, pages 153-166.
Crossref
Crossref
Jiyeon Ham, Whasun Lim, Fuller W. Bazer & Gwonhwa Song. (2017) Silibinin stimluates apoptosis by inducing generation of ROS and ER stress in human choriocarcinoma cells. Journal of Cellular Physiology 233:2, pages 1638-1649.
Crossref
Crossref
Zhuan-Li Bai, Vincent Tay, Shu-Zhong Guo, Juan Ren & Mao-Guo Shu. (2018) Silibinin Induced Human Glioblastoma Cell Apoptosis Concomitant with Autophagy through Simultaneous Inhibition of mTOR and YAP. BioMed Research International 2018, pages 1-10.
Crossref
Crossref
Vasanti Suvarna, Pramila Chaubey, Preeti C. Sangave & Ashish K. Singh. 2018. Polyphenols: Prevention and Treatment of Human Disease. Polyphenols: Prevention and Treatment of Human Disease
125
136
.
Cha Kuen, Sharida Fakurazi, Siti Othman & Mas Masarudin. (2017) Increased Loading, Efficacy and Sustained Release of Silibinin, a Poorly Soluble Drug Using Hydrophobically-Modified Chitosan Nanoparticles for Enhanced Delivery of Anticancer Drug Delivery Systems. Nanomaterials 7:11, pages 379.
Crossref
Crossref
Camila Ribeiro de Avelar, Emile Miranda Pereira, Priscila Ribas de Farias Costa, Rosângela Passos de Jesus & Lucivalda Pereira Magalhães de Oliveira. (2017) Effect of silymarin on biochemical indicators in patients with liver disease: Systematic review with meta-analysis. World Journal of Gastroenterology 23:27, pages 5004.
Crossref
Crossref
Vijay Mohan, Rajesh Agarwal & Rana P. Singh. (2016) A novel alkaloid, evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells. Biochemical and Biophysical Research Communications 477:4, pages 1065-1071.
Crossref
Crossref
Nesreen G. Abd El-Haliem. (2016) The possible role of milk thistle extract on titanium dioxide nanoparticles-induced lung toxicity in male albino rat. The Egyptian Journal of Histology 39:2, pages 179-190.
Crossref
Crossref
Ibrahim M. El-Sherbiny, Nancy M. El-Baz & Amr Hefnawy. 2016. Nutraceuticals. Nutraceuticals
117
152
.
W.G. Jiang, A.J. Sanders, M. Katoh, H. Ungefroren, F. Gieseler, M. Prince, S.K. Thompson, M. Zollo, D. Spano, P. Dhawan, D. Sliva, P.R. Subbarayan, M. Sarkar, K. Honoki, H. Fujii, A.G. Georgakilas, A. Amedei, E. Niccolai, A. Amin, S.S. Ashraf, L. Ye, W.G. Helferich, X. Yang, C.S. Boosani, G. Guha, M.R. Ciriolo, K. Aquilano, S. Chen, A.S. Azmi, W.N. Keith, A. Bilsland, D. Bhakta, D. Halicka, S. Nowsheen, F. Pantano & D. Santini. (2015) Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Seminars in Cancer Biology 35, pages S244-S275.
Crossref
Crossref
Cynthia Tilley, Gagan Deep & Rajesh Agarwal. (2015) Chemopreventive opportunities to control basal cell carcinoma: Current perspectives. Molecular Carcinogenesis 54:9, pages 688-697.
Crossref
Crossref
SERDAR KALEMCI, YASAR TOPAL, SERKAN YASAR CELIK, NIGAR YILMAZ, HALIL BEYDILLI, MEHMET ILKAY KOSAR, NIGAR DIRICAN & IRFAN ALTUNTAS. (2015) Silibinin attenuates methotrexate-induced pulmonary injury by targeting oxidative stress. Experimental and Therapeutic Medicine 10:2, pages 503-507.
Crossref
Crossref
Joaquim Bosch-Barrera & Javier A. Menendez. (2015) Silibinin and STAT3: A natural way of targeting transcription factors for cancer therapy. Cancer Treatment Reviews 41:6, pages 540-546.
Crossref
Crossref
Zeynep Birsu Cincin, Miray Unlu, Bayram Kiran, Elif Sinem Bireller, Yusuf Baran & Bedia Cakmakoglu. (2015) Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells. Cellular Oncology 38:3, pages 195-204.
Crossref
Crossref
Feng Li, Zhenkun Ma, Zhenfeng Guan, Yule Chen, Kaijie Wu, Peng Guo, Xinyang Wang, Dalin He & Jin Zeng. (2015) Autophagy Induction by Silibinin Positively Contributes to Its Anti-Metastatic Capacity via AMPK/mTOR Pathway in Renal Cell Carcinoma. International Journal of Molecular Sciences 16:12, pages 8415-8429.
Crossref
Crossref
Peter Surai. (2015) Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants 4:1, pages 204-247.
Crossref
Crossref
Anne-Marie Baird, Derek Richard, Kenneth J. O’Byrne & Steven G. Gray. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
189
213
.
Yi-Xin Wang, Hong Cai, Gang Jiang, Tian-Bao Zhou & Hai Wu. (2014) Silibinin Inhibits Proliferation, Induces Apoptosis and Causes Cell Cycle Arrest in Human Gastric Cancer MGC803 Cells Via STAT3 Pathway Inhibition. Asian Pacific Journal of Cancer Prevention 15:16, pages 6791-6798.
Crossref
Crossref
Zeynep Birsu Cincin, Miray Unlu, Bayram Kiran, Elif Sinem Bireller, Yusuf Baran & Bedia Cakmakoglu. (2014) Molecular Mechanisms of Quercitrin-induced Apoptosis in Non-small Cell Lung Cancer. Archives of Medical Research 45:6, pages 445-454.
Crossref
Crossref
Seon Min Woo, Kyoung-jin Min, Shin Kim, Jong-Wook Park, Dong Eun Kim, Kyung-Soo Chun, Young Ho Kim, Tae-Jin Lee, Sang Hyun Kim, Yung Hyun Choi, Jong-Soo Chang & Taeg Kyu Kwon. (2014) Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation. Chemico-Biological Interactions 211, pages 36-43.
Crossref
Crossref